信立泰：2025年中报净利润为3.65亿元

Financial Performance - The company's total revenue is 2.131 billion yuan, with a net profit attributable to shareholders of 365 million yuan [1] - The net cash inflow from operating activities is 425 million yuan, which is a decrease of 108 million yuan compared to the same period last year, representing a year-on-year decline of 20.19% [1] Financial Ratios - The latest debt-to-asset ratio is 18.13%, an increase of 2.15 percentage points from the previous quarter [3] - The latest gross profit margin is 75.31%, a slight decrease of 0.01 percentage points from the previous quarter [3] - The latest return on equity (ROE) is 4.28%, down by 0.12 percentage points compared to the same period last year [3] Efficiency Metrics - The diluted earnings per share (EPS) is 0.33 yuan [4] - The latest total asset turnover ratio is 0.20 times, a decrease of 0.01 times compared to the same period last year, reflecting a year-on-year decline of 5.82% [4] - The latest inventory turnover ratio is 1.01 times, down by 0.22 times compared to the same period last year, indicating a year-on-year decline of 17.94% [4] Shareholder Structure - The number of shareholders is 24,000, with the top ten shareholders holding 772 million shares, accounting for 69.28% of the total share capital [4] - The largest shareholder is Xintai Pharmaceutical Co., Ltd., holding 56.99% of the shares [4]